Tirzepatide is a synthetic peptide developed for research purposes, classified as a dual receptor agonist targeting both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
You may notice slightly reduced appetite suppression during the extended gap, but one week of suboptimal levels will not meaningfully affect your long-term results
If youre an Aetna member considering these treatments, its essential to understand your coverage options
Meanwhile, the cost of Wegovy injections, which the company recently revised, is $199 at first and $349 after two months for self-paying patients
Europe - Significant market driven by strong healthcare systems, increasing geriatric population, widespread adoption of novel antidiabetic drugs, and government-backed chronic disease management programs
10.1016/j.cell.2012.03.042 37 DixonS